Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05535244
Title A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen (BCMA)-Exposed Participants With Relapsed/Refractory Multiple Myeloma (CAMMA 2)
Acronym CAMMA 2
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | ISR | FRA | ESP | DEU | BEL | AUS

Facility Status City State Zip Country Details
Mayo Clinic - Arizona Phoenix Arizona 85054 United States Details
University of Colorado Aurora Colorado 80045-2517 United States Details
Mayo Clinic-Jacksonville Jacksonville Florida 32224 United States Details
University of Maryland Greenebaum Cancer Center Baltimore Maryland 21201 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Mayo Clinic - Rochester Rochester Minnesota 55905 United States Details
Icahn School of Medicine at Mount Sinai (ISMMS); The Derald H. Ruttenberg Treatment Center New York New York 10029 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Tennessee Oncology - Nashville Nashville Tennessee 37203 United States Details
Methodist Hospital San Antonio Texas 78229 United States Details
Hunstman Cancer Institute Salt Lake City Utah 84112 United States Details
Calvary Mater Newcastle; Hematology Waratah New South Wales 2298 Australia Details
St Vincent's Hospital Melbourne Fitzroy Victoria 3065 Australia Details
UZ Leuven Gasthuisberg Leuven 3000 Belgium Details
CHU NANTES - Hôtel Dieu; Service d'Hematologie Clinique Nantes 44093 France Details
APHP - Hospital Saint Louis Paris 75475 France Details
CHU de Poitiers - La Miletrie; Oncologie hematologique - Pole Regional de Cancerologie Poitiers 86021 France Details
CAMPUS BENJAMIN FRANKLIN CharitéCentrum 14 Med.Klinik f.Hämatologie u.Onkologie Berlin 12200 Germany Details
Universitätsklinikum Hamburg-Eppendorf Onkologisches Zentrum Medizinische Klinik II Hamburg 20246 Germany Details
Klinik der Uni zu Köln; Klinik für Innere Medizin Köln 50924 Germany Details
Universitätsklinikum Tübingen Medizinische UNI-Klinik und Poliklinik Abt. Innere Medizin II Tübingen 72076 Germany Details
Universitätsklinikum Würzburg; Medizinische Klinik und Poliklinik II; Hämatologie / Onkologie Würzburg 97080 Germany Details
Hadassah Ein Karem Hospital; Haematology Jerusalem 9112001 Israel Details
Sheba Medical Center; Tel Hashomer Ramat Gan 5262100 Israel Details
Sourasky Medical Centre Tel-Aviv 6423906 Israel Details
Policlinico S.Orsola-Malpighi;Istituto di Ematologia "Seragnoli" Bologna Emilia-Romagna 40138 Italy Details
ASST PAPA GIOVANNI XXIII; Ematologia Bergamo Lombardia 24127 Italy Details
Fond. IRCCS Istituto Nazionale Tumori; S. C. Ematologia Milano Lombardia 20133 Italy Details
A.O. Città della Salute e della Scienza D - Osp. S. Giov. Battista Molinette; Ematologia I Torino Piemonte 10126 Italy Details
Clinica Universitaria de Navarra; Servicio de Hematologia Pamplona Navarra 31008 Spain Details
Hospital Clínic i Provincial; Servicio de Hematología y Oncología Barcelona 08036 Spain Details
Clinica Universidad de Navarra Madrid; Servicio de Hematología Madrid 28027 Spain Details
Hospital Univ. 12 de Octubre; Servicio de Hematologia Madrid 28041 Spain Details
Hospital Universitario la Fe; Servicio de Hematologia Valencia 46026 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field